Skip to content

Drug interactions

Givosiran + Lidocaine

Severity: Minor

Givosiran and Lidocaine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Givosiran reduces CYP1A2 activity, and lidocaine is partly cleared by CYP1A2 (with CYP3A4 as the main route). Lidocaine exposure could increase modestly, which matters mainly with systemic or prolonged infusions.

What this interaction means in plain words

Givosiran and Lidocaine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Givosiran belongs to Miscellaneous; Lidocaine belongs to Cardiovascular.

Evidence level: Low

Why it happens

Givosiran-related reduction in CYP1A2 activity decreases lidocaine metabolism.

What to do

No adjustment for local use; for systemic lidocaine, monitor for toxicity symptoms and consider dose reduction.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Givosiran and Lidocaine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Givosiran with Lidocaine?

MediHelp rates the interaction as minor. Givosiran and Lidocaine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Givosiran reduces CYP1A2 activity, and lidocaine is partly cleared by CYP1A2 (with CYP3A4 as the main route). Lidocaine exposure could increase modestly, which matters mainly with systemic or prolonged infusions.

How serious is the interaction between Givosiran and Lidocaine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No adjustment for local use; for systemic lidocaine, monitor for toxicity symptoms and consider dose reduction.

What other medicines interact with Lidocaine?

MediHelp also lists interactions of Lidocaine with, for example, Bupivacaine liposome, Disopyramide, Ex vivo expanded autologous human corneal epithelial cells containing stem cells. The full list is on the Lidocaine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in